Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific Herald.
Press releases published on March 26, 2025
In-vitro diagnostics market to grow at a CAGR of 5.1% (2024 – 2030): Wissen Research
GlobeNewswire
·
March 26, 2025
Sheridan, March 26, 2025 (GLOBE NEWSWIRE) -- According to the latest market report published by Wissen Research, the global in-vitro diagnostics market is projected to be valued at 82.5 billion in 2023. Furthermore, the market is expected to grow at a CAGR …
The TSX Celebrates the 30 Years Listing Anniversary of Globex Mining Enterprises Inc.
GlobeNewswire
·
March 26, 2025
ROUYN-NORANDA, Quebec, March 26, 2025 (GLOBE NEWSWIRE) -- Yesterday, the Toronto Stock Exchange surprised the Globex Team with this announcement posted on the TSX building downtown in the City of Toronto. Globex Mining Enterprises Inc. (GMX-TSX) was …
New Novel 'Outback Odyssey' Sparks Inspiration for a New National Flag Reflecting Australia’s Rich Cultural Heritage
EIN Presswire
·
March 26, 2025
Sydney, Australia – Acclaimed historical fiction author Paul Rushworth-Brown unveils 'Outback Odyssey', a powerful novel that goes beyond adventure. SYDNEY, NSW, AUSTRALIA, March 26, 2025 /EINPresswire.com/ -- Acclaimed historical fiction author Paul …
Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment
GlobeNewswire
·
March 26, 2025
Preclinical Data to Support Advancement Toward First-in-Human Clinical Trials SARASOTA, FL, March 26, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel …
Bluejay Therapeutics Announces First Patient Dosed in AZURE-1 Global Pivotal Clinical Trial Evaluating Brelovitug (BJT-778) as a Monotherapy Treatment for Chronic Hepatitis D
GlobeNewswire
·
March 26, 2025
REDWOOD CITY, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Bluejay Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing therapeutics for serious viral and liver diseases, today announced that the first …
High-Grade Discoveries Enhance Scale of Pelé Project
GlobeNewswire
·
March 26, 2025
SYDNEY, March 26, 2025 (GLOBE NEWSWIRE) -- Brazilian Rare Earths Limited (ASX: BRE / OTCQX: BRELY) is pleased to report the results of exploration drilling at the Pelé Target 1 Project, located in Bahia, Brazil. The Pelé Project is hosted within the Volta …
Western Metallica Announces Amended Bridge Financing and Director Resignation
GlobeNewswire
·
March 26, 2025
TORONTO, March 26, 2025 (GLOBE NEWSWIRE) -- Western Metallica Resources Corp. (TSXV: WMS) (“Western Metallica” or the “Company”) announces that it has amended its previously announced bridge financing (see press release dated January 16, 2025) for an …
Vast Secures AUD 700,000 Grant from Australia-Singapore Initiative for Decarbonising Shipping to Progress World-First South Australia Solar Fuels Project
GlobeNewswire
·
March 26, 2025
SA Solar Fuels will have the capacity to produce 7,500 tonnes per annum of sustainable fuels to meet the growing demand from maritime and aviation industries Funding will support industry-leading optimisation work as the project advances towards FEED …
Programming Genomes, the next AI frontier
EIN Presswire
·
March 26, 2025
Recent advances show that genomes are programmable in ways never previously imagined and amenable to AI implementations CHARLESTOWN, MA, UNITED STATES, March 26, 2025 /EINPresswire.com/ -- We all learned that genomes are made up of B-DNA. The idea that …
Aligos Therapeutics Presents Positive Data at APASL 2025
GlobeNewswire
·
March 26, 2025
SOUTH SAN FRANCISCO, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral …
Rio Silver Acquires the Minas Maria Norte Project in a Prolific Mining District in Southern Peru
GlobeNewswire
·
March 26, 2025
VANCOUVER, British Columbia, March 26, 2025 (GLOBE NEWSWIRE) -- Rio Silver Inc. (“Rio Silver” or the “Company”) (TSX.V: RYO) (OTC: RYOOF) announces that it has signed a definitive agreement for the acquisition of the Minas Maria Norte (“Maria Norte” or the …
Dewpoint Therapeutics announces upcoming presentations at AACR 2025
GlobeNewswire
·
March 26, 2025
Dewpoint will present two posters at AACR Condensate modulators (c-mods) demonstrate robust anti-tumor effects across multiple types of cancer C-mods modulate the oncogenic function of historically undruggable targets MYC and beta catenin BOSTON, March 26, …
E-Star BioTech Announces Presentation During 2025 Annual Meeting of the American College of Cardiology
GlobeNewswire
·
March 26, 2025
NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- E-Star BioTech, LLC (“E-Star” or the “Company”), an innovative developer of novel peptides designed to treat cardiovascular, metabolic, and kidney diseases, today announced its presentation of clinical trial …
NevGold Discovers Further Significant Gold-Antimony Results: 2.46 g/t AuEq Over 86.9 Meters (1.11 g/t Au And 0.30% Antimony), Including 5.75 g/t AuEq Over 12.8 Meters (1.83 g/t Au And 0.87% Antimony), and Also Including 6.77 g/t AuEq Over 6.7 Meters…
GlobeNewswire
·
March 26, 2025
Vancouver, British Columbia, March 26, 2025 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce that it has discovered further significant gold-antimony (“Antimony”, “Sb”) …
Acumen Pharmaceuticals Completes Enrollment of ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer’s Disease
GlobeNewswire
·
March 26, 2025
NEWTON, Mass., March 26, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s …
Samfine Creation Holdings Group Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
GlobeNewswire
·
March 26, 2025
HONG KONG, March 26, 2025 (GLOBE NEWSWIRE) -- Samfine Creation Holdings Group Limited (the “Company”) received a letter from the Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that based on the closing bid price of …
Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights
GlobeNewswire
·
March 26, 2025
Orbit Phase 3 study of setrusumab in osteogenesis imperfecta progressing toward second interim analysis, expected mid-2025 Alvelestat granted Orphan Designation by the European Commission for treatment of Alpha-1 Antitrypsin Deficiency-associated Lung …
VR Resources Reports Drilling Results at Silverback Copper-Gold Project in Northwest Ontario
GlobeNewswire
·
March 26, 2025
VANCOUVER, British Columbia, March 26, 2025 (GLOBE NEWSWIRE) -- VR Resources Ltd. (TSX.V: VRR, FSE: 5VR; OTCBB: VRRCF), the "Company", or “VR”, is pleased to report results from its first winter drill program at the Silverback copper-gold project in …
Mineral Wool Market Size to Reach a Value of US$ 23.07 Billion by 2031, Exclusive Report by The Insight Partners
GlobeNewswire
·
March 26, 2025
US …
Medicenna to Provide Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming American Association for Cancer Research Annual Meeting
GlobeNewswire
·
March 26, 2025
Additional data from the MDNA11 ABILITY-1 trial to be presented at the Annual Meeting Pre-clinical data on Medicenna’s first-in-class Masked and Tumor Targeted Bifunctional anti-PD1-IL2 Superkine, MDNA113, will also be presented TORONTO and HOUSTON, March …